
Sign up to save your podcasts
Or
In the first of our annual festive songs celebrating the science of the past year, we pay homage to Ozempic, or Semaglutide, that's able to tackle obesity, diabetes and potentially a whole lot more.
We gather an all-star cast and see how well they can remember some of the big science stories from 2024 in our annual festive quiz.
In the second of our festive songs, we look at CAR-T cells. These engineered immune cells have shown great promise at tackling cancer, but these treatments are not without their drawbacks.
Every year, Nature’s 10 highlights some of the people who have helped shape science over the past 12 months. We hear about a few of the people who made the 2024 list, including an economist who now needs to run a country, a Russian science-sleuth, a researcher who’s been sounding the alarm on Mpox, and a PhD student who won a salary bump for researchers in Canada.
News Feature: Nature’s 10
Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.
Hosted on Acast. See acast.com/privacy for more information.
4.5
702702 ratings
In the first of our annual festive songs celebrating the science of the past year, we pay homage to Ozempic, or Semaglutide, that's able to tackle obesity, diabetes and potentially a whole lot more.
We gather an all-star cast and see how well they can remember some of the big science stories from 2024 in our annual festive quiz.
In the second of our festive songs, we look at CAR-T cells. These engineered immune cells have shown great promise at tackling cancer, but these treatments are not without their drawbacks.
Every year, Nature’s 10 highlights some of the people who have helped shape science over the past 12 months. We hear about a few of the people who made the 2024 list, including an economist who now needs to run a country, a Russian science-sleuth, a researcher who’s been sounding the alarm on Mpox, and a PhD student who won a salary bump for researchers in Canada.
News Feature: Nature’s 10
Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.
Hosted on Acast. See acast.com/privacy for more information.
6,089 Listeners
937 Listeners
596 Listeners
806 Listeners
609 Listeners
415 Listeners
1,371 Listeners
109 Listeners
345 Listeners
953 Listeners
0 Listeners
17 Listeners
4 Listeners
355 Listeners
393 Listeners
481 Listeners
114 Listeners
496 Listeners